Stockreport

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

Pliant Therapeutics, Inc.  (PLRX) 
PDF SOUTH SAN FRANCISCO, June 13, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and dev [Read more]